Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2011 1
2012 2
2013 1
2014 1
2016 1
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Tumour-specific amplitude-modulated radiofrequency electromagnetic fields induce differentiation of hepatocellular carcinoma via targeting Cav3.2 T-type voltage-gated calcium channels and Ca2+ influx.
Jimenez H, Wang M, Zimmerman JW, Pennison MJ, Sharma S, Surratt T, Xu ZX, Brezovich I, Absher D, Myers RM, DeYoung B, Caudell DL, Chen D, Lo HW, Lin HK, Godwin DW, Olivier M, Ghanekar A, Chen K, Miller LD, Gong Y, Capstick M, D'Agostino RB Jr, Munden R, Merle P, Barbault A, Blackstock AW, Bonkovsky HL, Yang GY, Jin G, Liu L, Zhang W, Watabe K, Blackman CF, Pasche BC. Jimenez H, et al. Among authors: pennison mj. EBioMedicine. 2019 Jun;44:209-224. doi: 10.1016/j.ebiom.2019.05.034. Epub 2019 May 31. EBioMedicine. 2019. PMID: 31160272 Free PMC article.
TGFBR1 and cancer susceptibility.
Pasche B, Pennison MJ, Jimenez H, Wang M. Pasche B, et al. Among authors: pennison mj. Trans Am Clin Climatol Assoc. 2014;125:300-12. Trans Am Clin Climatol Assoc. 2014. PMID: 25125747 Free PMC article. Review.
Lynch Syndrome Testing: A Missed Opportunity in the Era of Precision Medicine.
Pasche B, Pennison MJ, DeYoung B. Pasche B, et al. Among authors: pennison mj. JAMA. 2016 Jul 5;316(1):38-9. doi: 10.1001/jama.2016.8291. JAMA. 2016. PMID: 27380341 No abstract available.
Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies.
Zimmerman JW, Jimenez H, Pennison MJ, Brezovich I, Morgan D, Mudry A, Costa FP, Barbault A, Pasche B. Zimmerman JW, et al. Among authors: pennison mj. Chin J Cancer. 2013 Nov;32(11):573-81. doi: 10.5732/cjc.013.10177. Chin J Cancer. 2013. PMID: 24206915 Free PMC article. Review.
Characterization of the colorectal cancer-associated enhancer MYC-335 at 8q24: the role of rs67491583.
Tuupanen S, Yan J, Turunen M, Gylfe AE, Kaasinen E, Li L, Eng C, Culver DA, Kalady MF, Pennison MJ, Pasche B, Manne U, de la Chapelle A, Hampel H, Henderson BE, Marchand LL, Hautaniemi S, Askhtorab H, Smoot D, Sandler RS, Keku T, Kupfer SS, Ellis NA, Haiman CA, Taipale J, Aaltonen LA. Tuupanen S, et al. Among authors: pennison mj. Cancer Genet. 2012 Jan-Feb;205(1-2):25-33. doi: 10.1016/j.cancergen.2012.01.005. Cancer Genet. 2012. PMID: 22429595 Free PMC article.
Cancer cell proliferation is inhibited by specific modulation frequencies.
Zimmerman JW, Pennison MJ, Brezovich I, Yi N, Yang CT, Ramaker R, Absher D, Myers RM, Kuster N, Costa FP, Barbault A, Pasche B. Zimmerman JW, et al. Among authors: pennison mj. Br J Cancer. 2012 Jan 17;106(2):307-13. doi: 10.1038/bjc.2011.523. Epub 2011 Dec 1. Br J Cancer. 2012. PMID: 22134506 Free PMC article.
Germline allele-specific expression of TGFBR1 confers an increased risk of colorectal cancer.
Valle L, Serena-Acedo T, Liyanarachchi S, Hampel H, Comeras I, Li Z, Zeng Q, Zhang HT, Pennison MJ, Sadim M, Pasche B, Tanner SM, de la Chapelle A. Valle L, et al. Among authors: pennison mj. Science. 2008 Sep 5;321(5894):1361-5. doi: 10.1126/science.1159397. Epub 2008 Aug 14. Science. 2008. PMID: 18703712 Free PMC article.
Constitutively decreased TGFBR1 allelic expression is a common finding in colorectal cancer and is associated with three TGFBR1 SNPs.
Pasche B, Wisinski KB, Sadim M, Kaklamani V, Pennison MJ, Zeng Q, Bellam N, Zimmerman J, Yi N, Zhang K, Baron J, Stram DO, Hayes MG. Pasche B, et al. Among authors: pennison mj. J Exp Clin Cancer Res. 2010 May 25;29(1):57. doi: 10.1186/1756-9966-29-57. J Exp Clin Cancer Res. 2010. PMID: 20500843 Free PMC article.
Feedback